Assessment of harms, benefits and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios

Assessment of harms, benefits and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios

Bibliographic Details
Main Authors:	A. Getaneh, E. Heijnsdijk, M. Roobol, H. De. Koning
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320326495

Similar Items

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
by: Abraham M. Getaneh, et al.
Published: (2020-10-01)

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model
by: Abraham M. Getaneh, et al.
Published: (2021-06-01)

The role of modelling in the policy decision making process for cancer screening: example of prostate specific antigen screening
by: Abraham M Getaneh, et al.
Published: (2019-07-01)

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
by: Tom Callender, et al.
Published: (2019-12-01)

Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
by: Nikolai Mühlberger, et al.
Published: (2017-06-01)

Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
by: Mary Dillon, et al.
Published: (2018-08-01)

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios
by: Nadine Zielonke, et al.
Published: (2021-07-01)

Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria
by: Beate Jahn, et al.
Published: (2019-12-01)

Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates
by: Jie-Bin Lew, et al.
Published: (2019-07-01)

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
by: Ester Vilaprinyo, et al.
Published: (2014-01-01)

Prostate cancer screening in Europe and Asia
by: Kai Zhang, et al.
Published: (2017-04-01)

Establishing thresholds for important benefits considering the harms of screening interventions
by: Lise Mørkved Helsingen, et al.
Published: (2020-12-01)

Pregnant Women's Perceptions of Harms and Benefits of Mental Health Screening.
by: Dawn Kingston, et al.
Published: (2015-01-01)

Form 230
by: Lucian CERNUȘCA
Published: (2020-05-01)

Benefits and Harms of Breast Screening: Focused on Updated Korean Guideline for Breast Cancer Screening
by: Soo-Yeon Kim, et al.
Published: (2016-03-01)

Screening for prostate cancer: what are the benefits ?
by: Murad Lesmana
Published: (2015-12-01)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
by: S Lucas Goede, et al.
Published: (2017-01-01)

Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study
by: Jie-Bin Lew, MPH, et al.
Published: (2017-07-01)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
by: Abraham M. Getaneh, et al.
Published: (2021-01-01)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
by: Bruce Leff, et al.
Published: (2019-08-01)

Harm, Benefit, and Non-Identity
by: Algander, Per
Published: (2013)

The Costs and Benefits of Animal Experiments: An Evaluation with Bias. By Andrew Knight. Palgrave Macmillan: Basingstoke, Hampshire, UK, 2011; Hardcover, 272 pp; ISBN 978-0-230-57686-5; Paperback, ISBN: 978-0-230-57687-2
by: Susanne Prankel
Published: (2012-01-01)

Cost-effectiveness of screening for prostate cancer
by: A. D. Kaprin, et al.
Published: (2020-02-01)

High throughput virtual screening of 230 billion molecular solar heat battery candidates
by: Mads Koerstz, et al.
Published: (2021-02-01)

Cost-Benefit Analysis on Energy Alternative Scenarios for Taiwan Power Sector
by: Su-Min Chiu, et al.
Published: (2008)

CO2 reduction costs and benefits in transport: socio-technical scenarios
by: Heikki Liimatainen, et al.
Published: (2018-12-01)

How do cancer screening guidelines trade off benefits versus harms and burdens of screening? A systematic survey
by: Lise Mørkved Helsingen, et al.
Published: (2020-12-01)

A framework for organizing and selecting quantitative approaches for benefit-harm assessment
by: Puhan Milo A, et al.
Published: (2012-11-01)

Prostate cancer screening in the elderly: A yes or no issue? Long term follow-up data from ERSPC Rotterdam
by: M.J. Roobol, et al.
Published: (2020-07-01)

Critical Overview on the Benefits and Harms of Aspirin
by: Chun Shing Kwok, et al.
Published: (2010-05-01)

"Benefit or not harm" smoking in the mentally ill
by: Michael Kourakos
Published: (2016-06-01)

Benefits or Harms of No Child Left Behind
by: Block, Judy
Published: (2006)

DAILY HEMATOLOGIC ASSESSMENT DURING A 230-KM MULTISTAGE ULTRAMARATHON
by: Luciele Guerra Minuzzi, et al.

Cost-Benefit Assessments of Distributed Power GenerationBased On Micro Gas Turbine
by: Chien-hung Chen, et al.
Published: (2007)

Cost-containment protocols for prostate core needle biopsies: hypothetical scenarios to reduce procedural costs
by: Roberto Ruiz-Cordero, et al.
Published: (2019-03-01)

230 Websites and Blogs for Terrorism Research
by: Judith Tinnes
Published: (2013-06-01)

RECL 230 - 20-May-82
Published: (2011)

RECL 230 - 9-Aug-84
Published: (2011)

RECL 230 - 30-Jul-85
Published: (2011)

Screening for chronic kidney disease: preventing harm or harming the healthy?
by: Maarten W Taal
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_bts3srftlfdtdke0s5412jp1gn